CAS: 596-38-3; 9-Phenyl-9H-Xanthen-9-Ol

该化合物是属于Xanthenes化合物类别的有机化合物,具有一种由三环导合系统组成的Xanthene核心结构,在9级位置被一个苯基组和氢氧基组所取代,其典型特征是黄色至橙色和浮质,因此对各种应用,包括作为荧光染色和光化研究感兴趣;氢氧基体组的存在有助于其溶解性,并影响其再活动,特别是形成氢结.此外,9-Phenylxan-9-ol可以参与各种化学反应,例如氧化和替代,这可能与合成有机化学有关,其独特的结构特征和特性使它成为研究和工业应用的宝贵化合物,特别是在材料科学和光质学领域.

结构式图片

上下游产品

CAS号117-99-7 2-羟基二苯甲酮 | CAS号88284-48-4 2-(三甲基硅)苯基三氟甲烷磺酸盐 | CAS号90-47-1 呫吨酮 | CAS号100-58-3 苯基溴化镁 | CAS号591-51-5 苯基锂 | CAS号42506-03-6 9-氯-9-苯基氧杂蒽 | CAS号3246-80-8 9-phenyl-9H-xanthene | CAS号101-84-8 二苯醚 | CAS号91-01-0 二苯甲醇 | CAS号100-52-7 苯甲醛 | CAS号90-47-1 呫吨酮 | CAS号155816-67-4 4-phenylnonan-2-one | CAS号644-08-6 4-甲基联苯 | CAS号58-72-0 三苯乙烯 | CAS号2770-17-4 11-Phenyldibenz... | CAS号6630-78-0 9-(3-nitropheny... | CAS号89192-82-5 [2-(2-hydroxyph... | CAS号61744-33-0 9-azido-9-pheny... | CAS号3976-34-9 2,6-DIMETHYLBIPHENYL

合成工艺路线路线简述

    📜5'-O-Pixylthymidine 以 水,乙腈 作为反应溶剂,以83%的收率获得产物9-苯基苯二烯-9-醇
    参考文献:The Pixyl (Px) Group: A Novel Photocleavable Protecting Group For Primary Alcohols
    标题:The Pixyl (Px) Group: A Novel Photocleavable Protecting Group For Primary Alcohols
    摘要:The 9-Phenylxanthyl (Pixyl Or Px) Moiety Has Been Investigated As A Potential Photocleavable Protecting Group For Primary Alcohols. Alcohols 2A-E Were Protected In Good Yield By Treatment With 9-Chloro-9-Phenylxanthene In Dry Pyridine At Room Temperature. Irradiation Of The Alcohol Derivatives In Neutral Aqueous Acetonitrile Regenerates 2A-E And The 9-Phenylxanthyl Alcohol. (C) 1998 Elsevier Science Ltd. All Rights Reserved.
    DOI:10.1016/s0040-4039(98)00013-6

    海关参考信息

    专利信息


    专利号:US-5936080-A
    优先权日:1996-05-24
    标题 :Compositions and methods for the synthesis of organophosphorus derivatives
    发明人:STEC WOJCIECH J; WOZNIAK LUCYNA
    权利人:GENTA INC; POLSKA AKADEMIA NAUK INSTYTUT
    摘要:New organophosphorus mononucleoside derivatives, methods of their synthesis and methods for the synthesis of organophosphorus dinucleotide derivatives utilizing the organophosphorus mononucleosides are provided. Synthesized organophosphorus mononucleoside derivatives of the present invention are characterized by the formula; ##STR1## Organophosphorus dinucleoside derivatives prepared from the synthesis methods provided in the present invention are characterized by the formula; ##STR2##

    专利号:US-5856465-A
    优先权日:1996-05-24
    标 题:Compositions and methods for the synthesis of chirally pure organophosphorus nucleoside derivatives
    发明人:STEC WOJCIECH JACEK; WOZNIAK LUCYNA
    权利人:POLSKA AKAD NAUK CENTRUM
    摘要:Methods for the stereospecific synthesis of chirally pure organophosphorus dinucleotide derivatives and nucleoside monomer synthons used in their synthesis are provided. These methods allow for conversion of nucleoside intermediates of unchosen sense of P-chirality to nucleoside monomer synthons of chosen sense of P-chirality. Also provided are novel nucleoside intermediates useful in such methods.

    专利号:EP-0850248-B1
    优先权日:1995-09-01
    标 题 :Compositions and methods for the synthesis of organophosphorus derivatives
    发明人:STEC WOJCIECH J; WOZNIAK LUCYNA
    权利人:POLSKA AKAD NAUK CENTRUM
    摘要:Methods for the stereospecific synthesis of chirally pure organophosphorus dinucleotide derivatives and nucleoside monomer synthons used in their synthesis are provided. These methods allow for conversion of nucleoside intermediates of unchosen sense of P-chirality to nucleoside monomer synthons of chosen sense of P-chirality. Also provided are novel nucleoside intermediates useful in such methods.

    专利号:US-6407223-B1
    优先权日:1997-04-25
    标 题 :Process for the synthesis of modified P-chiral nucleotide analogues
    发明人:STEC WOJCIECH J; WOZNIAK LUCYNA A; CHWOROS ARKADIUSZ; PYZOWSKI JAROSLAW
    权利人:POLSKA AKADEMIA NAUK CENIRUM B
    摘要:The process of the instant invention is drawn to the synthesis of modified P-chiral nucleotide analogues in the form of pure diastereomers possessing preselected configuration at the P-atom. Oligonucleotides prepared by the method of the invention containing P-chiral compounds have enhanced hybridization and transporting properties.

    专利号:US-4835319-A
    优先权日:1987-11-09
    标题:Process for the manufacture of 1,4-bis(4-phenoxybenzoyl)benzene with a zeolite catalyst
    发明人:CORBIN DAVID R; KUMPINSKY ENIO; VIDAL ANTONIO
    权利人:DU PONT
    摘要:1,4-Bis(4-phenoxybenzoyl)benzene is made in a heterogeneous system by a reaction of diphenyl ether with 1,4-benzenedicarbonyl chloride at 190°-250° C. in the presence of a zeolite catalyst having a ring structure containing 12 oxygen atoms, which can be either an activated zeolite in hydrogen form or an iron-exchanged zeolite, which zeolite can be readily separated from the hot liquid phase in the reaction mixture. The mole ratio of diphenyl ether to 1,4-dicarbonyl chloride, when the catalyst is in hydrogen form, is about 50-80:1; when the catalyst is in iron-exhcanged form, it is about 10-50:1, and the weight ratio of 1,4-benzenedicarbonyl chloride to zeolite in hydrogen form is 3:1 to 1:2, while the ratio of 1,4-benzenedicarbonyl chloride to zeolite in iron-exchanged form is 10:1 to 1:32. The product readily crystallizes in a high state of purity from the cooled solution. 1,4-Bis(4-phenoxybenzoyl)benzene is a vaulable intermediate in the synthesis of polyetherketone resins.

    专利号:US-2007276139-A1
    优先权日:2004-02-10
    标题:Substituted Pixyl Protecting Groups for Oligonucleotide Synthesis
    发明人:SONG QUANLAI; KHAMMUNGKHUNE SAK; ROSS BRUCE S; GRIFFEY RICHARD H
    权利人:SONG QUANLAI; KHAMMUNGKHUNE SAK; ROSS BRUCE S; GRIFFEY RICHARD H
    摘要:The present invention describes an improved hydroxyl protecting group of formula (1), wherein R 2 and R 7 are specified substituents and Q is O, S, NR 10 or N(Câ•?O)R 10 .

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:S109 | PARCEDC | List of 7074 potential endocrine disrupting compounds (EDCs) by PARC T4.2 | DOI:10.5281/zenodo.10944198
    参考文献:10.1016/j.bmc.2010.01.018
    摘要:Giri R, Goodell JR, Xing C, Benoit A, Kaur H, Hiasa H, Ferguson DM. Synthesis and cancer cell cytotoxicity of substituted xanthenes. Bioorg Med Chem. 2010 Feb 15;18(4):1456–63. doi: 10.1016/j.bmc.2010.01.018.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知